Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Mulder

Showing results (261-270 of 289) with videos related to

Pageof 29
Sort By:
Journal of Crohn'S & Colitis|January 26, 2023
Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry StudyMelek Simsek, Femke Schepers, Sigal Kaplan, et al.
World Journal of Gastroenterology|October 20, 2012
Similar fecal immunochemical test results in screening and referral colorectal cancerSietze T van Turenhout, Leo G M van Rossum, Frank A Oort, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 3, 2006
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]M Y V Homs, E W Steyerberg, W M H Eijkenboom, et al.
World Journal of Gastroenterology|October 14, 2005
On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patientsNanne-K-H de Boer, Luc-J-J Derijks, Lennard-P-L Gilissen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 8, 2010
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancersJochim S Terhaar sive Droste, Frank A Oort, René W M van der Hulst, et al.
BMC Gastroenterology|July 26, 2012
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort studyJochim S Terhaar sive Droste, Sietze T van Turenhout, Frank A Oort, et al.
The American Journal of Gastroenterology|November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationL J W Bosch, V Melotte, S Mongera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Chromosome 5q loss in colorectal flat adenomasQuirinus J M Voorham, Beatriz Carvalho, Angela J Spiertz, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2009
Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood testF A Oort, J S Terhaar Sive Droste, R W M Van Der Hulst, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2013
Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitisNicole M F van Gerven, Ynto S de Boer, Antonie Zwiers, et al.
Pageof 29

Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Journal of Crohn'S & Colitis|January 26, 2023
Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry StudyMelek Simsek, Femke Schepers, Sigal Kaplan, et al.
World Journal of Gastroenterology|October 20, 2012
Similar fecal immunochemical test results in screening and referral colorectal cancerSietze T van Turenhout, Leo G M van Rossum, Frank A Oort, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 3, 2006
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]M Y V Homs, E W Steyerberg, W M H Eijkenboom, et al.
World Journal of Gastroenterology|October 14, 2005
On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patientsNanne-K-H de Boer, Luc-J-J Derijks, Lennard-P-L Gilissen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 8, 2010
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancersJochim S Terhaar sive Droste, Frank A Oort, René W M van der Hulst, et al.
BMC Gastroenterology|July 26, 2012
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort studyJochim S Terhaar sive Droste, Sietze T van Turenhout, Frank A Oort, et al.
The American Journal of Gastroenterology|November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationL J W Bosch, V Melotte, S Mongera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
Chromosome 5q loss in colorectal flat adenomasQuirinus J M Voorham, Beatriz Carvalho, Angela J Spiertz, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2009
Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood testF A Oort, J S Terhaar Sive Droste, R W M Van Der Hulst, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2013
Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitisNicole M F van Gerven, Ynto S de Boer, Antonie Zwiers, et al.
Pageof 29